Daclatasvir


( Last Updated : February 13, 2015)
Generic Name:
Daclatasvir
Project Status:
Complete
Therapeutic Area:
Hepatitis C, Chronic
Manufacturer:
Bristol-Myers Squibb Canada Inc.
Call for patient/clinician input open:
Brand Name:
Daklinza
Project Line:
Reimbursement Review
Project Number:
SR0417-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Hepatitis C, chronic
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: